Abstract
In 1970, The United States government enacted the Controlled Substances Act (CSA). The CSA usurped all existing federal laws regulating controlled substances and established three primary criteria for evaluating all drugs: medical utility, potential for abuse, and safety of the substance. Since the passage of the CSA, the federal government has generally taken the lead when regulating drugs; however, a psychoactive plant, Salvia divinorum, has illustrated some of the problems when evaluating hallucinogenic drugs under the current regulation scheme. Beginning in the late 1990s, S. divinorum began to appear for sale on the Internet and in “head shops,” often marketed as a “legal high.” The availability of a “legal high” has concerned many state lawmakers, but failed to gain the attention of federal drug regulators. To date, nearly half of the individual United States have chosen to regulate S. divinorum. One of the reasons for the regulation is that hallucinogens are not typically considered to have medical utility and have often been deemed to have no recognized medical utility. Furthermore, hallucinogens tend to be niche drugs with no real potential for abuse or addiction. As recently witnessed with the case of S. divinorum, the plant may not have a recognized medical utility, but the plant does not seem to present any real danger either. These circumstances can be problematic, since the rush to regulate a “legal high” seems to take precedence over determining if S. divinorum has medical utility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acker, C. J. (2002). Creating the American junkie: Addiction research in the classic era of narcotic control. Baltimore, MD: Johns Hopkins.
Akers, R. L. (1992). Drugs, alcohol, and society: Social structure, process and policy. Belmont, CA: Wadsworth.
Baggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. (2010). Use patterns of self-reported effects of Salvia divinorum: An Internet-based survey. Drug and Alcohol Dependence, 111(3), 250–256.
Blake, K. (2006, November 14). CBS 4 investigates herb “Salvia divinorum.” CBS 4 Investigates. Retrieved from http://cbs4denver.com/video/?id=24272@kcnc.dayport.com.
Bonnie, R. J., & Whitebread, C. H., II. (1999). The marijuana conviction: A history of marijuana prohibition in the United States (2nd ed.). New York, NY: The Lindesmith Center.
Brecher, E. M., & the Editors of Consumer Reports (1972). Licit and illicit drugs. Boston, MA: Little Brown.
Bucheler, R., Gleiter, C. H., Schwoerer, P., & Gaertner, I. (2005). Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (diviner’s sage). Pharmacopsychiatry, 38(1), 1–5.
Bullis, R. K. (2008). The “vine of the soul” vs. the controlled substances act: Implications of the hoasca case. Journal of Psychoactive Drugs, 40(2), 193–199.
Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., et al. (1999). Pharmacokinetics of hoasca alkaloids in healthy humans. Journal of Ethnopharmacology, 65(3), 243–256.
Casselman, I., & Heinrich, M. (2011). Novel use patterns of Salvia divinorum: Unobtrusive observation using YouTube. Journal of Ethnopharmacology, 138(3), 662–667.
Courtwright, D. T. (1982). Dark paradise: A history of opiate addiction in America. Cambridge, MA: Harvard University Press.
Courtwright, D. T. (2001). Forces of habit: Drugs and the making of the modern world. Cambridge, MA: Harvard University Press.
Courtwright, D. T. (2004). The Controlled Substances act: How a “big tent” reform became a punitive drug law. Drug and Alcohol Dependence, 76(1), 9–15.
Dennehy, C. E., Tsourounis, C., & Miler, A. E. (2005). Evaluation of herbal dietary supplements marketed on the Internet for recreational use. The Annals of Pharmacotherapy, 39(10), 1634–1639.
Eisner, B. (1994). Ecstasy: The MDMA story (2nd ed.). Berkeley, CA: Ronin Publishing.
Emboden, W. (1979). Narcotic plants: Hallucinogens, stimulants, inebriants, and hypnotics, their origins and uses. New York, NY: Macmillan.
Engel, P. (1999, March 11). Testimony before the House Subcommittee on Oversight and Investigations of the 106th congress.
Feeney, K., & Labate, B. C. (2014). The expansion of Brazilian ayahuasca religions: Law, culture and locality (this volume).
Fischelis, R. P. (1938). What is a patent or proprietary medicine? The Scientific Monthly, 46(1), 25–31.
Friedman, L. M. (1994). Crime and punishment in American history. New York, NY: Basic Books.
Gahlinger, P. (2004). Illegal drugs: A complete guide to their history, chemistry, use and abuse. New York, NY: Plume Books.
Gonzalez, D., Riba, J., Bouso, J. C., Gomez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157–162.
Goode, E. (2011). Drugs in American society (8th ed.). New York, NY: McGraw-Hill.
Griffin, O. H., III, Miller, B. L., & Khey, D. N. (2008). Legally high? Legal considerations of Salvia divinorum. Journal of Psychoactive Drugs, 40(2), 183–191.
Griffiths, R. R., & Grob, C. S. (2010). Hallucinogens as medicine. Scientific American, 303, 77–79.
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665.
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283.
Grob, C. S., Mckenna, D. J., Callaway, J. C., Brito, G. S., Neves, E. S., Oberlaender, G., et al. (1996). Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. The Journal of Nervous and Mental Disease, 184(2), 86–94.
Grundmann, O., Phipps, S. M., Zadezensky, I., & Butterweck, V. (2007). Salvia divinorum and salvinorin A: An update on pharmacology and analytical methodology. Planta Medica, 73(10), 1039–1046.
Halpern, J. H., & Pope, H. G., Jr. (2001). Hallucinogens on the Internet: A vast new source of underground drug information. American Journal of Psychiatry, 158(3), 481–483.
Hawthorne, F. (2005). Inside the FDA: The business and politics behind the drugs we take and the food we eat. Hoboken, NJ: Wiley.
Himmelstein, J. L. (1983). The strange career of marihuana: Politics and ideology of drug control in America. Westport, CT: Greenwood Press.
Hofmann, A. (2005). LSD: My problem child: Reflections on sacred drugs, mysticism and science. Saline, MI: MAPS.
Jaffe, J. A. (1985). Impact of scheduling on the practice of medicine and biomedical research. Drug and Alcohol Dependence, 14(3–4), 403–418.
Jenkins, P. (1999). Synthetic panics: The symbolic politics of designer drugs. New York, NY: New York University Press.
Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620.
Kelly, B. C. (2011). Legally tripping: A qualitative profile of Salvia divinorum use among young adults. Journal of Psychoactive Drugs, 43(1), 46–54.
Khey, D. N., Miller, B. L., & Griffin, O. H. (2008). Salvia divinorum use among a college student sample. Journal of Drug Education, 38(3), 297–306.
Labate, B. C., dos Santos, R. G., Anderson, B., Mercante, M., & Barbosa, P. C. R. (2012). The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research. In B. C. Labate & E. MacRae (Eds.), Ayahuasca, ritual and religion in Brazil (pp. 205–227). Sheffield, UK: Equinox.
Labate, B. C., & Feeney, K. (2012). Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. International Journal of Drug Policy, 23(2), 154–161.
Lange, J. E., Daniel, J., Homer, K., Reed, M. B., & Clapp, J. D. (2010). Salvia divinorum: Effects and use among YouTube users. Drug and Alcohol Dependence, 108(1–2), 138–140.
Lange, J. E., Reed, M. B., Ketchie Croff, J. M., & Clapp, J. D. (2008). College student use of Salvia divinorum. Drug Alcohol Dependence, 94(1–3), 263–266.
Lee, M. A., & Shlain, B. (1994). Acid dreams: The complete social history of LSD. New York, NY: Grove Press.
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453–1461.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129.
Miller, B. L., Griffin, O. H., III, Gibson, C. L., & Khey, D. N. (2009). Trippin’ on Sally D: Exploring predictors of Salvia divinorum experimentation. Journal of Criminal Justice, 37(4), 396–403.
Moran, T., & Culhane, M. (2007, October 3). Parents blame exotic plant for son’s suicide. ABC Nightline. Retrieved on September 29, 2012 from http://abcnews.go.com/Nightline/story?id=3685391&page=1#.UGZupVGAeSO.
Murphy, J., Kim A., Hagood, H., Richards, A., Augustine, C., Kroutil, L., & Sage, A. (2011, September). Twitter feeds and Google search query surveillance: Can they supplement survey data collection. Paper presented at Association for Survey Computing 6th International Conference, Bristol, UK.
Musto, D. F. (1999). The American disease: Origins of narcotic control (3rd ed.). New York, NY: Oxford University Press.
Perron, B. E., Ahmedani, B. K., Vaughn, M. G., Glass, J. E., Abdon, A., & Wu, L. (2012). Use of Salvia divinorum in a nationally representative sample. The American Journal of Drug and Alcohol Abuse, 38(1), 108–113.
Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences, 78(5), 527–531.
Rasmussen, N. (2008). America’s first amphetamine epidemic 1929–1971: A quantitative and qualitative retrospective with implications for the present. American Journal of Public Health, 98(6), 974–985.
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S. A., et al. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous k opioid selective agonist. Proceedings of the National Academy of Sciences of the United States of America, 99, 11934–11939.
Santos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. M. (2007). Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology, 112(3), 507–513.
Schultes, R. E., Hofmann, A., & Ratsch, C. (2001). Plants of the gods: Their sacred, healing, and hallucinogenic powers. Rochester, VT: Healing Arts Press.
Sheppard, S. G. (1994). A preliminary investigation of ibogaine: Case reports and recommendations for further study. Journal of Substance Abuse Treatment, 11(4), 379–385.
Siebert, D. J. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43(1), 53–56.
Siebert, D. J. (2006). The Salvia divinorum user’s guide. Retrieved on September 29, 2012 from http://sagewisdom.org/userguide.html.
Singh, S. (2007). Adolescent salvia substance abuse. Addiction, 102(5), 823–824.
Spillane, J. F. (2000). Cocaine: From medical marvel to modern menace in the United States, 1884–1920. Baltimore, MD: Johns Hopkins.
Spillane, J. F. (2004). Debating the Controlled Substances Act. Drug and Alcohol Dependence, 76(1), 17–29.
Stogner, J., Khey, D. N., Griffin, O. H., III, Miller, B. L., & Boman, J. H., IV. (2012). Regulating a novel drug: An evolution of changes in use of Salvia divinorum in the first year of Florida’s ban. International Journal of Drug Policy, 23(6), 512–521.
Strassman, R. J. (1996). Human psychopharmacology of N,N-dimethyltryptamine. Behavioural Brain Research, 73(1–2), 121–124.
Sutherland, E. H. (1940). White-collar criminality. American Sociological Review, 5(1), 1–12.
Valdes, L. J. (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26(3), 277–283.
Vohra, R., Seefeld, A., Cantrell, F. L., & Clark, R. F. (2011). Salvia divinorum: Exposures reported to a statewide poison control system over 10 years. The Journal of Emergency Medicine, 40(6), 643–650.
Vortherms, T. A., & Roth, B. L. (2006). Salvinorin A: From natural product to human therapeutics. Molecular Interventions, 6(5), 257–265.
Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets, Harvard University, 20(3), 77–84.
Wu, L., Woody, G. E., Yang, C., Li, J., & Blazer, D. G. (2011). Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse Rehabilitation, 2011(2), 53–68.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Griffin, O.H. (2014). Salvia divinorum, Hallucinogens, and the Determination of Medical Utility. In: Labate, B., Cavnar, C. (eds) Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40957-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-40957-8_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40956-1
Online ISBN: 978-3-642-40957-8
eBook Packages: Humanities, Social Sciences and LawLaw and Criminology (R0)